Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19619102 | 1.00 | ALDH1A1 (0.33) | ALDH1A1RECQLCYP1A2CYP2D6HIF1A | |
| SCHEMBL16549232 | 0.82 | CHRNB4 (0.36) | CHRNB4CHRNA3 | |
| SCHEMBL16316097 | 0.77 | TSHR (0.38) | ALDH1A1RECQLCYP1A2CYP2D6 | |
| SCHEMBL19286233 | 0.77 | TSHR (0.38) | ALDH1A1RECQLCYP1A2CYP2D6 | |
| SCHEMBL19286241 | 0.77 | TSHR (0.38) | ALDH1A1RECQLCYP1A2CYP2D6 | |
| SCHEMBL25159725 | 0.77 | TSHR (0.38) | ALDH1A1RECQLCYP1A2CYP2D6 | |
| SCHEMBL25159570 | 0.77 | TSHR (0.38) | ALDH1A1RECQLCYP1A2CYP2D6 | |
| SCHEMBL17470033 | 0.77 | HIF1A (0.37) | RECQLCYP1A2CYP2D6HIF1A | |
| SCHEMBL19286298 | 0.77 | HIF1A (0.37) | RECQLCYP1A2CYP2D6HIF1A | |
| SCHEMBL13150731 | 0.77 | KCNA5 (0.33) | ALDH1A1RECQLCHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11572592-B2 | Labelling compounds and their use in assays | BINX HEALTH LIMITED (GB) | 2023-02-07 | — | — | US | disclosed |
| US-20220025440-A1 | LABELLING COMPOUNDS AND THEIR USE IN ASSAYS | BINX HEALTH LIMITED (GB) | 2022-01-27 | — | — | US | disclosed |
| US-10968490-B2 | Labelling compounds and their use in assays | BINX HEALTH LIMITED (GB) | 2021-04-06 | — | — | US | disclosed |
| US-20180037937-A1 | Labelling Compounds and Their Use in Assays | KREOS CAPITAL VII (UK) LIMITED (GB) | 2018-02-08 | — | — | US | disclosed |
| EP-3055317-B1 | LABELLING COMPOUNDS AND THEIR USE IN ASSAYS | ATLAS GENETICS LTD (GB) | 2018-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037937-A1 | Labelling Compounds and Their Use in Assays | CYP2F1, CYP4F3, CYP4F2 | ALDH1A1 314/4885RECQL 1447/4885CYP1A2 37/4885 |
| US-20220025440-A1 | LABELLING COMPOUNDS AND THEIR USE IN ASSAYS | CYP2F1, CYP4F3, CYP4F2 | ALDH1A1 314/4885RECQL 1447/4885CYP1A2 37/4885 |
| US-11572592-B2 | Labelling compounds and their use in assays | CYP2F1, CYP4F3, CYP4F2 | ALDH1A1 314/4885RECQL 1447/4885CYP1A2 37/4885 |
| US-10968490-B2 | Labelling compounds and their use in assays | CYP2F1, CYP4F3, CYP4F2 | ALDH1A1 314/4885RECQL 1447/4885CYP1A2 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.